Medline INC Form 4 insider transactions

Medline Inc.'s Chief Commercial Officer, Douglas P. Golwas, reported significant acquisitions of Class B Common Stock, Common Units, and Incentive Units related to the company's IPO reclassification, alongside a new grant of restricted stock units.

Medline Executive Vice President William J. Abrams reported the reclassification of equity interests and a new restricted stock unit grant, primarily linked to the company's IPO.

Medline Inc. CEO James M. Boyle reported substantial acquisitions of Class B and Class A Common Stock, along with various incentive units, primarily linked to reclassification and RSU grants.

CP Circle Holdings, L.P. has transferred all its beneficial ownership in Medline Inc. securities to an affiliated entity.

Carlyle Mozart Coinvestment Holdings, L.P. reported a transfer of over 15 million Class A Common Stock shares of Medline Inc. to an affiliated entity for no consideration.